Neogen Corporation Advertising Revenue Cost (Deprecated 2018-01-31)
Neogen Corporation (NEOG) reported Advertising Revenue Cost (Deprecated 2018-01-31) of $1.64 million for the 12-month period ending 2017-05-31, per its 10-K filed 2017-07-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingRevenueCost · last filed 2017-07-28
- Neogen Corporation advertising revenue cost (deprecated 2018-01-31) for fiscal 2017 was $1.64M, a 12.30% increase from fiscal 2016.
- Neogen Corporation advertising revenue cost (deprecated 2018-01-31) for fiscal 2016 was $1.46M, a 6.71% increase from fiscal 2015.
- Neogen Corporation advertising revenue cost (deprecated 2018-01-31) for fiscal 2015 was $1.37M, a 2.01% increase from fiscal 2014.
- Neogen Corporation advertising revenue cost (deprecated 2018-01-31) for fiscal 2014 was $1.34M, a 27.39% increase from fiscal 2013.
| Period end | Advertising Revenue Cost (Deprecated 2018-01-31) 12 month | Advertising Revenue Cost (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|
| 2017-05-31 | $1.64M 10-K · filed 2017-07-28 | |
| 2016-05-31 | $1.46M 10-K · filed 2017-07-28 | |
| 2015-05-31 | $1.37M 10-K · filed 2017-07-28 | |
| 2014-05-31 | $1.34M 10-K · filed 2016-07-29 | |
| 2013-05-31 | $1.05M 10-K · filed 2015-07-30 | |
| 2012-05-31 | $1.00M 10-K · filed 2014-07-30 | $993.00K 10-K · filed 2012-07-30 |
| 2011-05-31 | $677.00K 10-K · filed 2013-07-30 | |
| 2010-05-31 | $633.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |